Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/6/2017
SIETES contiene 91846 citas

 
 
 1 a 20 de 3540 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol Drug Saf 2017;26:635-41. [Ref.ID 101626]
2. Cita con resumen
Okano A, Isley NA, Boger DL. Peripheral modifications of [?[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics. Proceedings of the National Academy of Sciences of the United States of America 2017:13 de marzo. [Ref.ID 101615]
3.Tiene citas relacionadas Cita con resumen
Xia Z, Friedlander RM. Minocycline in multiple sclerosis - Compelling results but too early to tell. N Engl J Med 2017;376:2191-3. [Ref.ID 101610]
4.Tiene citas relacionadas Cita con resumen
Metz LM, Li DKB, Traboulsee AL, Duquette P, Eliasziw M, Cerchiaro G, Greenfield J, Riddehough A, Yeung M, Kremenchutzky YM, Vorobeychik G, Freedman MS, Bhan V, Blevins G, Marriott JJ, Grand'Maison F, Lee L, Thibault M, Hill MD, Yong VW, for the Minocycline in MS Study Team. Trial of minocycline in a clinically isolated syndrome of multiple sclerosis. N Engl J Med 2017;376:2122-33. [Ref.ID 101609]
5. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
6. Cita con resumen
Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. Can Med Assoc J 2017;189:E625-33. [Ref.ID 101551]
7. Cita con resumen
Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Froslev T, Molokhia M, Diemberger I, Sturkenboom M. Use of azithromycin and risk of ventricular arrhytmia. CMAJ 2017;189:E560-8. [Ref.ID 101536]
8.Enlace a cita original Cita con resumen
Tariq R, Singh S, Gupta A, Pardi DS, Khanna S. Association of gastric acid suppression with recurrent Clostridium difficile infection. A systematic review and meta-analysis. JAMA Intern Med 2017:27 de marzo. [Ref.ID 101506]
9. Cita con resumen
Anónimo. Rifaximine et encéphalopatie hépatique. Prescrire 2017;37:175-6. [Ref.ID 101454]
10. Cita con resumen
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim Y-S, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr M-B, for the MODIFY I and MODIFY II Investigators. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med 2017;376:305-17. [Ref.ID 101394]
12. Cita con resumen
Anónimo. Délamanid et tuberculose pulmonaire multirésistante. Prescrire 2017;37:10. [Ref.ID 101359]
13. Cita con resumen
Gisbert JP, Molina-Infante J. Tratamiento actual de la infección por Helicobacter pylori. Med Clin (Barc) 2017;148:20-2. [Ref.ID 101339]
14.Tiene citas relacionadas
Kenna MA. Acute otitis media - The long and the short of it. N Engl J Med 2016;373:2492-6. [Ref.ID 101035]
15.Tiene citas relacionadas Cita con resumen
Hoberman A, Paradise JL, Rockette HE, Kearney DH, Bhatnagar S, Shope TR, Martin JM, Kurs-Lasky M, Copelli SJ, Colborn DK, Block SL, Labella JJ, Lynch TG, Cohen NL, Haralam MA, Pope MA, Nagg JP, Green MD, Shaikh N. Shortened antimicrobial treatment for acute otitis media in young children. N Engl J Med 2016;373:2446-56. [Ref.ID 101033]
16. Cita con resumen
Patel M, Agarwal K, Arshad Q, Hariri M, Rea P, Seemungal BM, Golding JF, Harcourt JP, Bronstein AM. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial. Lancet 2016;388:2753-62. [Ref.ID 101028]
17.Enlace a cita original
Hawcutt DB, Russell N-J, Maqsood H, Kouranloo K, Gomberg S, Waitt C, Sharp A, Riordan A, Turner MA. Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001–2010: content and utility analysis . Br J Clin Pharmacol 2016;82:1601-12. [Ref.ID 101026]
19.Tiene citas relacionadas Cita con resumen
Kessler C, Ward MJ, McNaughton CD. Reducing adverse drug events: the need to rethink outpatient prescribing. JAMA 2016;316:2092-3. [Ref.ID 100974]
20. Cita con resumen
Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson NC, Ashby D, Chauhan A, AZALEA Trial Team. Azithromycin for acute exacerbations of asthma: the AZALEA randomized clinical trial. JAMA 2016;176:1630-7. [Ref.ID 100957]
Seleccionar todas
 
 1 a 20 de 3540 siguiente >>